Cargando…
Nebulized Heparin to Reduce COVID-19-induced Acute Lung Injury: A Prospective Observational Study
BACKGROUND: High mortality due to COVID-19 disease has been a serious concern, a few of the causes being disseminated intravascular coagulation (DIC) and venous thromboembolism. Considering this, some experts have used heparin. However, its role still needs to be validated. MATERIALS AND METHODS: Th...
Autores principales: | Gupta, Bhavna, Chandrakar, Saurabh, Gupta, Nidhi, Jain, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028714/ https://www.ncbi.nlm.nih.gov/pubmed/36960112 http://dx.doi.org/10.5005/jp-journals-10071-24420 |
Ejemplares similares
-
Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2010) -
Role of Nebulized Heparin in Clinical Outcome of COVID-19 Patients with Respiratory Symptoms: A Systematic Review
por: Gupta, Bhavna, et al.
Publicado: (2023) -
Arterial Blood Gas as a Predictor of Mortality in COVID Pneumonia Patients Initiated on Noninvasive Mechanical Ventilation: A Retrospective Analysis
por: Gupta, Bhavna, et al.
Publicado: (2021) -
A phase 1 trial of nebulized heparin in acute lung injury
por: Dixon, B, et al.
Publicado: (2008) -
Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury
por: Xie, Nianlin, et al.
Publicado: (2017)